# Immunovant, Inc.: Form 4, filed Dec 12, 2025

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: 4
- Filed: 2025-12-12
- Accepted by EDGAR: Dec 12, 2025, 17:17 ET
- Period: 2025-12-12
- Accession: 0001140361-25-045409
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000114036125045409/xslF345X05/form4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000114036125045409/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000114036125045409/xslF345X05/form4.xml

Filed Dec 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-045409. Last ingested by Listed: Oct 30, 2026, 16:48 ET. No prices; not investment advice.